Denali Capital Acquisition Corp. (DECA) Adds $18M PIPE to Longevity Deal
Denali Capital (NASDAQ:DECA) announced in an 8-K that it has added $18 million in equity funding to its combination with biotech firm Longevity through the sale of newly issued series A preferred shares. ...READ MORE
